UNITAID and its partners are launching a new injectable treatment once morest the transmission of HIV/AIDS, in Brazil and South Africa.
People on pre-exposure prophylaxis (PrEP) in these two countries will now be able to switch from taking daily oral tablets to an injection every two months, to prevent exposure to HIV during sex without a condom.
The populations most at risk will be targeted, we listen to the details of Hervé Verhoosel, spokesperson for UNITAID
(Sound extract: Hervé Verhoosel, spokesperson for UNITAID; remarks recorded by Alpha Diallo)
